1. Pink Sheet
  2. >>Geography
  3. >>Europe

Drug Development Must Be Patient-Centric; Adherence Schemes Must Follow

 
• By Faraz Kermani

Global health systems are losing billions of dollars by not introducing schemes to tackle drug adherence, but are heading in the right direction with patient-centric drug development.

Pharmaceutical manufacturers are consciously seeking to involve patients at every stage of the medicines development process - but unless drug adherence is effectively managed, this exercise may prove fruitless.

Speaking at the plenary session of the Drug Information Association’s 26th EuroMeeting in Vienna, Austria, on March 25, Michael Rosenblatt, Executive Vice President and Chief Medical Officer at Merck...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

US ‘Most Favored Nation’ Pricing Could be Game Changer for Drug Access In Germany

 
• By Francesca Bruce

In this first in a series of articles looking at the potential impact of the MFN drug pricing policy on European pharmaceutical markets, EUCOPE’s Alexander Natz tells the Pink Sheet why the US policy underscores the importance of confidential net pricing.

ClinicalTrials.gov Or ISRCTN: Getting Transparency Right For UK Trials

 
• By Vibha Sharma

ISRCTN’s systems are being redesigned to facilitate compliance with upcoming requirements in the UK’s clinical trials legislation.

Spain Slashes Wait Between EU Drug Authorization And Financing Decisions

 
• By Francesca Bruce

Spanish authorities say that that timelines for drug reimbursement decisions can be improved further with the right submissions from companies.

Spain Beats England To Tevimbra Reimbursement Recommendations

 
• By Francesca Bruce

Spanish authorities have published more pricing and reimbursement reports as part of a new drive to increase transparency.

More from Geography